Increased DDR1 expression in several human cancers, such as renal clear cell carcinoma, breast cancer, NSCLC, prostate cancer, esophageal cancer, and hepatocellular carcinoma, indicates DDR1 impact on oncogenesis[6-11]. This evidence concerns the gene DDR1 and esophageal cancer.